By the same authors

Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

Research output: Book/ReportCommissioned report

Standard

Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. / CRD and CHE Technology Assessment Group ; Norman, Gill; Rice, Stephen J; Spackman, Eldon; Stirk, Lisa; Danso-Appiah, Tony; Suh, D; Palmer, Stephen John; Eastwood, Alison Jane.

Centre for Reviews and Dissemination/ Centre for Health Economics, 2010.

Research output: Book/ReportCommissioned report

Harvard

CRD and CHE Technology Assessment Group, Norman, G, Rice, SJ, Spackman, E, Stirk, L, Danso-Appiah, T, Suh, D, Palmer, SJ & Eastwood, AJ 2010, Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Centre for Reviews and Dissemination/ Centre for Health Economics.

APA

CRD and CHE Technology Assessment Group, Norman, G., Rice, S. J., Spackman, E., Stirk, L., Danso-Appiah, T., ... Eastwood, A. J. (2010). Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Centre for Reviews and Dissemination/ Centre for Health Economics.

Vancouver

CRD and CHE Technology Assessment Group, Norman G, Rice SJ, Spackman E, Stirk L, Danso-Appiah T et al. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Centre for Reviews and Dissemination/ Centre for Health Economics, 2010.

Author

CRD and CHE Technology Assessment Group ; Norman, Gill ; Rice, Stephen J ; Spackman, Eldon ; Stirk, Lisa ; Danso-Appiah, Tony ; Suh, D ; Palmer, Stephen John ; Eastwood, Alison Jane. / Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Centre for Reviews and Dissemination/ Centre for Health Economics, 2010.

Bibtex - Download

@book{d8dd139697a7410e98d548b090d3b2c5,
title = "Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction",
author = "{CRD and CHE Technology Assessment Group} and Gill Norman and Rice, {Stephen J} and Eldon Spackman and Lisa Stirk and Tony Danso-Appiah and D Suh and Palmer, {Stephen John} and Eastwood, {Alison Jane}",
year = "2010",
month = "5",
language = "English",
publisher = "Centre for Reviews and Dissemination/ Centre for Health Economics",

}

RIS (suitable for import to EndNote) - Download

TY - BOOK

T1 - Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

AU - CRD and CHE Technology Assessment Group

AU - Norman, Gill

AU - Rice, Stephen J

AU - Spackman, Eldon

AU - Stirk, Lisa

AU - Danso-Appiah, Tony

AU - Suh, D

AU - Palmer, Stephen John

AU - Eastwood, Alison Jane

PY - 2010/5

Y1 - 2010/5

M3 - Commissioned report

BT - Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

PB - Centre for Reviews and Dissemination/ Centre for Health Economics

ER -